Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05860413 · ClinicalTrials.gov registry record · NA
Intermittent Fasting for the Treatment of Type 2 Diabetes Mellitus
A NA study, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 57
- Enrollment target
NCT05860413 is a NA study that has completed, run by University of Kansas Medical Center. The registered enrollment target is 57 participants.
The verdict
NCT05860413, a NA study, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
Study Summary
To test whether a lifestyle program featuring one of two forms of intermittent fasting (IER or TRE) can feasibly and effectively improve glycemia in patients with type 2 diabetes, and potentially induce diabetes remission.
Interventions
- BEHAVIORAL Time Restricted Eating (TRE)
- BEHAVIORAL Intermittent energy restriction (IER)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2023-01-24 |
| Est. Completion | 2025-05-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05860413
The ClinicalTrials.gov registry entry for NCT05860413 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Time Restricted Eating (TRE) is the first listed.
NCT05860413 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05860413 about?
NCT05860413 is a clinical study titled "Intermittent Fasting for the Treatment of Type 2 Diabetes Mellitus". To test whether a lifestyle program featuring one of two forms of intermittent fasting (IER or TRE) can feasibly and effectively improve glycemia in patients with type 2 diabetes, and potentially induce diabetes remission.
What is the current status of trial NCT05860413?
This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2023-01-24. Estimated completion is 2025-05-20.
What interventions are being tested in trial NCT05860413?
The interventions under investigation include: Time Restricted Eating (TRE) (BEHAVIORAL), Intermittent energy restriction (IER) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05860413?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.